← back to search

C. Andrew Boswell

Amgen (United States) · US
Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research interests include Antibody, Biology, Pharmacokinetics, Nuclear medicine, Medicine, and Blood–brain barrier.
h-index
citations
253
works
7
NIH funding
primary concept
email

Recent publications

Measurement of specific and nonspecific tissue uptake of antibodies in tumor by SPECT imaging and nonlinear compartmental modeling
EJNMMI Research 2025cited by 2position: lastdoi
Preclinical development of ZED8, an 89Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy
European Journal of Nuclear Medicine and Molecular Imaging 2022cited by 10position: middledoi
Correction to: Preclinical development of ZED8, an 89Zr immuno‑PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy
European Journal of Nuclear Medicine and Molecular Imaging 2022cited by 0position: middledoi
Effect of Modulating FcRn Binding on Direct and Pretargeted Tumor Uptake of Full-length Antibodies
Molecular Cancer Therapeutics 2020cited by 14position: lastdoi
Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational Pharmacology
The AAPS Journal 2018cited by 21position: lastdoi
Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult mice
Scientific Reports 2018cited by 11position: middledoi
Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies
Neuron 2015cited by 195position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gregory Z. Ferl · Gene Therapy Laboratory5 papers (2018–2025)Danielle Mandikian · University of California, Davis3 papers (2018–2020) · 3 papers (2015–2020) · 2 papers (2022–2022) · 2 papers (2022–2022) · 2 papers (2022–2022) · 2 papers (2022–2022)Tanja S. Zabka · Amgen (United States)2 papers (2022–2022)Alex de Crespigny · Gene Therapy Laboratory2 papers (2022–2022)Jan Mařı́k · Gene Therapy Laboratory2 papers (2022–2022) · 2 papers (2022–2022)Jason Ho · National Institutes of Health2 papers (2020–2025)Sandra Sanabria Bohórquez · KU Leuven2 papers (2022–2022) · 2 papers (2022–2022)Christine Yu · St. Jude Children's Research Hospital2 papers (2022–2022)Simon‐Peter Williams · Gene Therapy Laboratory2 papers (2022–2022)Hanine Rafidi · University of California, Davis2 papers (2018–2020) · 2 papers (2022–2022) · 2 papers (2022–2022)Shravan Kumar Sriraman · Northeastern University2 papers (2022–2022)